Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.
2.

Pathogenesis and treatment of lipodystrophy: what clinicians need to know.

Sattler FR.

Top HIV Med. 2008 Oct-Nov;16(4):127-33. Review.

3.

Pathogenesis and management of lipoatrophy.

Tungsiripat M, McComsey G.

Curr HIV/AIDS Rep. 2008 May;5(2):55-63. Review.

PMID:
18510890
4.

Management of morphologic changes associated with antiretroviral use in HIV-infected patients.

Wohl DA, Brown TT.

J Acquir Immune Defic Syndr. 2008 Sep 1;49 Suppl 2:S93-S100. doi: 10.1097/QAI.0b013e318186521a. Review.

PMID:
18725818
5.

Peroxisome proliferator-activated receptor gamma agonists in kidney disease--future promise, present fears.

Mao Z, Ong AC.

Nephron Clin Pract. 2009;112(4):c230-41. doi: 10.1159/000224789. Epub 2009 Jun 16. Review.

6.

Disorders of body fat distribution in HIV-1-infected patients.

Moreno S, Miralles C, Negredo E, Domingo P, Estrada V, Gutiérrez F, Lozano F, Martínez E.

AIDS Rev. 2009 Jul-Sep;11(3):126-34. Review.

PMID:
19654854
7.

[Side effects of antiretroviral therapy--skin manifestations].

Esser S.

MMW Fortschr Med. 2008 Apr 28;150 Spec No 1:8, 10-1. Review. German. No abstract available.

PMID:
19024907
8.

Panniculitis and lipodystrophy.

Eberhard BA, Ilowite NT.

Curr Opin Rheumatol. 2002 Sep;14(5):566-70. Review.

PMID:
12192256
9.

Clinical management of HIV-associated lipodystrophy.

Pirmohamed M.

Curr Opin Lipidol. 2009 Aug;20(4):309-14. doi: 10.1097/MOL.0b013e32832d3bb1. Review.

PMID:
19494771
10.

Peroxisome proliferator-activated receptor gamma in bladder cancer: a promising therapeutic target.

Mansure JJ, Nassim R, Kassouf W.

Cancer Biol Ther. 2009 Apr;8(7):6-15. Review.

PMID:
19417560
11.
12.

Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer.

Inamoto T, Shah JB, Kamat AM.

Urol Oncol. 2009 Nov-Dec;27(6):585-91. doi: 10.1016/j.urolonc.2008.11.002. Epub 2009 Jan 22. Review.

PMID:
19162510
13.

Dietary modulation of peroxisome proliferator-activated receptor gamma.

Marion-Letellier R, Déchelotte P, Iacucci M, Ghosh S.

Gut. 2009 Apr;58(4):586-93. doi: 10.1136/gut.2008.162859. Epub 2008 Nov 18. Review.

PMID:
19017686
14.

[Tenofovir as a strategy to avoid or limit adverse effects].

Portilla J.

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:19-24. Review. Spanish.

PMID:
19195434

Supplemental Content

Support Center